The Europe automotive parts remanufacturing market Growth Accelerated by Increased Focus on Sustainability

Europe Automotive Parts Remanufacturing Market

The automotive parts remanufacturing market in Europe involves the rebuilding of end-of-life cores into like-new parts. Remanufacturing of automotive parts such as engines, transmissions, and turbochargers helps reduce raw material usage and waste generation. These parts undergo disassembly, cleaning, inspection, replacement or remanufacturing of worn components, reassembly, and testing to ensure like-new performance.

The Europe automotive parts remanufacturing market is estimated to be valued at US$ 15.34 Mn in 2023 and is expected to exhibit a CAGR of 38.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

 

Market Dynamics:

Regulatory policies supporting sustainable practices play a major role in driving the growth of the Europe automotive parts remanufacturing market. Strict legislation such as the European Union's End-of-Life Vehicles Directive promotes reuse, recycling, and recovery of vehicles and their components. Remanufacturing helps reduce the environmental impact of raw material extraction and waste generation from manufacturing processes. It is estimated to conserve around 85-95% of the embodied energy content of original equipment compared to new parts production. The growth of the automotive industry and rising vehicle parc in Europe further support the remanufacturing market by providing an ample supply of core components for rebuilding.

 

SWOT Analysis

Strength: The Europe automotive parts remanufacturing market is expected to have a solid aftermarket demand for remanufactured parts. The existing fleet of vehicles provide a large remanufacturing opportunity. Strict emission regulations will also drive more consumers towards opting for remanufactured parts which are cheaper than new ones.

Weakness: Lack of standardized procedures for remanufacturing across all part categories can affect quality assurance. Higher investment and more complex operations involved in parts remanufacturing compared to manufacturing of new parts.

Opportunity: Increasing vehicle repair and service activities provide ample opportunities for growth of parts remanufacturing industry. Growing environmental concern regarding sustainable transportation will boost adoption of remanufactured auto components.

Threats: Introduction of new technologies in vehicles may reduce demand for certain conventional parts in long run. Price pressure from low-cost new components imported from other regions.

 

Key Takeaways

The Europe Automotive Parts Remanufacturing Market Share is expected to witness high growth over the forecast period of 2023 to 2030 supported by strong demand for cost-effective alternatives. The Europe automotive parts remanufacturing market is estimated to be valued at US$ 15.34 Mn in 2023 and is expected to exhibit a CAGR of 38% over the forecast period 2023 to 2030.

 

Regional analysis

The Europe automotive parts remanufacturing market is dominated by Germany, United Kingdom, Italy and France who collectively accounts for over 80% of market share. Germany has the highest number of automotive vehicles in operation providing largest remanufacturing potential. It is also a major automotive production base with presence of OEMs like Volkswagen, Daimler, and BMW. U.K is second largest market driven by strong automotive aftermarket industry. However, Eastern European markets like Poland and Czech Republic are expected to witness fastest growth during the forecast period supported by increasing vehicle fleet.

 

Key players

Key players operating in the Europe Automotive Parts Remanufacturing Market are AnaSpec, Inc., BTG International Inc., Midwest Reman, LLC, Walker Manufacturing, restorparts, and Detroit Diesel Corporation. The market is currently led by companies based in Germany and U.K with local and regional players. However, consolidation activities are expected to increase with focus on partnerships and acquisitions.


Get More Insights Here

https://www.newswirestats.com/europe-automotive-parts-remanufacturing-market-size-share-growth-outlook-2023/

Comments

Post a Comment

Popular posts from this blog

"Global Heparin Market: Current Trends and Future Prospects"

Image
  Heparin, a crucial anticoagulant, has been a mainstay in the pharmaceutical industry for many years. It plays a pivotal role in preventing and treating conditions such as deep vein thrombosis, pulmonary embolism, and various cardiovascular diseases. As we delve into the current state of the heparin market, we will explore the trends, challenges, and opportunities that shape this vital segment of the pharmaceutical industry. Market Overview: The global heparin market has experienced steady growth over the years, driven by an aging population, increasing cases of cardiovascular diseases, and a rising awareness of the importance of anticoagulants in healthcare. Heparin is available in various forms, including unfractionated heparin (UFH) and low molecular weight heparin (LMWH), each with its own set of applications and market dynamics. Trends: 1.      Rising Demand for LMWH : Low molecular weight heparin is gaining popularity due to its ease of administr...
Read more

"Advancements in Cystic Fibrosis Treatment: A Comprehensive Market Analysis"

Image
  The cystic fibrosis market has seen significant advancements and changes in recent years. Cystic fibrosis is a genetic disorder that affects the lungs and digestive system, leading to thick and sticky mucus production that can cause serious respiratory and digestive complications. The introduction of new therapies and treatments, such as CFTR modulators, has revolutionized the management of cystic fibrosis, offering hope and improved quality of life for patients. These drugs target the underlying genetic mutations responsible for the condition, helping to alleviate symptoms and slow disease progression. However, challenges remain in the cystic fibrosis market . Access to these ground-breaking therapies can be limited due to high costs, and ongoing research is needed to develop treatments for all genetic mutations associated with the disease. Additionally, the market continues to evolve as new therapies and innovations emerge. Collaborative efforts between pharmaceutical compani...
Read more

"Advancements in Thyroid Cancer Drugs Market: A Comprehensive Analysis"

Image
  Thyroid cancer is a relatively rare but potentially life-threatening condition that affects the thyroid gland. It has been on the radar of medical researchers and pharmaceutical companies for quite some time, leading to significant advancements in the development of thyroid cancer drugs. In this blog, we will explore the latest developments in the thyroid cancer drugs market and how they are shaping the landscape of treatment options for thyroid cancer patients. 1.      Targeted Therapies: One of the most notable advancements in thyroid cancer treatment is the emergence of targeted therapies. These drugs are designed to specifically target cancer cells, sparing healthy cells and reducing side effects. Some targeted therapies approved for thyroid cancer include Sorafenib and Lenvatinib, which have shown promise in slowing down tumor growth and improving patient outcomes. 2.      Immunotherapy: Immunotherapy has gained significant at...
Read more